Let's talk about how our products can help your research and therapeutic development.
Gene editing programs move beyond proving CRISPR works to determining whether it can scale. Delivery strategy shapes everything from manufacturing complexity to cost and clinical feasibility, and while viral vectors...
The FDA's new "plausible mechanism pathway," born from a groundbreaking bespoke CRISPR therapy case, signals a paradigm shift for complex biologics and personalized medicine. While this framework aims to streamline...
Choosing a GMP manufacturing partner is one of the most critical decisions in your clinical development journey. That’s why we created our GMP Open House—a unique opportunity to visit our...